US Patent Issued to UNIQURE BIOPHARMA on Feb. 4 for "Factor IX polypeptide mutant, its uses and a method for its production" (Italian Inventor)

ALEXANDRIA, Va., Feb. 5 -- United States Patent no. RE50,288, issued on Feb. 4, was assigned to UNIQURE BIOPHARMA B.V. (Amsterdam).

"Factor IX polypeptide mutant, its uses and a method for its production" was invented by Paolo Simioni (Padua, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are a modified FIX (factor IX) polypeptide comprising a leucine, cysteine, aspartic acid, glutamic acid, histidine, lysine, asparagine, glutamine or tyrosine in position 338; pharmaceutical preparations containing said modified FIX polypeptide; a nucleotide sequence coding for the modified FIX polypeptide; and a method for producing the modified FIX polypeptide."

The patent was filed on Jan. 12, 2023, under...